Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (600332) — Working Capital to Net Assets Ratio
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (600332) has a Working Capital to Net Assets ratio of 58.0% as of March 2026. Working capital of CN¥24.30 Billion (current assets of CN¥65.07 Billion minus current liabilities of CN¥40.76 Billion) is measured against net assets of CN¥41.89 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See how leveraged is Guangzhou Baiyunshan Pharmaceutical Hold's balance sheet to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Working Capital to Net Assets (1997–2025)
This chart shows how Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's Working Capital to Net Assets ratio has evolved across 29 annual periods from 1997 to 2025. As of March 2026, the ratio stands at 58.0%, reflecting working capital of CN¥24.30 Billion against net assets of CN¥41.89 Billion CNY. Check 600332 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (1997–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd from 1997 to 2025, covering 29 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Guangzhou Baiyunshan Pharmaceutical Hold market capitalisation.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 54.5% | CN¥22.39 Billion | CN¥41.12 Billion | CN¥61.52 Billion | CN¥39.12 Billion | ▲ +4.6 pp |
| 2024 | 49.9% | CN¥18.85 Billion | CN¥37.77 Billion | CN¥57.76 Billion | CN¥38.92 Billion | ▼ -3.9 pp |
| 2023 | 53.8% | CN¥19.75 Billion | CN¥36.68 Billion | CN¥55.98 Billion | CN¥36.24 Billion | ▼ -4.6 pp |
| 2022 | 58.5% | CN¥19.67 Billion | CN¥33.64 Billion | CN¥57.06 Billion | CN¥37.40 Billion | ▼ -7.1 pp |
| 2021 | 65.6% | CN¥20.56 Billion | CN¥31.33 Billion | CN¥52.81 Billion | CN¥32.25 Billion | ▲ +1.3 pp |
| 2020 | 64.4% | CN¥18.15 Billion | CN¥28.21 Billion | CN¥47.40 Billion | CN¥29.24 Billion | ▲ +0.5 pp |
| 2019 | 63.9% | CN¥16.61 Billion | CN¥25.99 Billion | CN¥45.98 Billion | CN¥29.38 Billion | ▼ -5.6 pp |
| 2018 | 69.5% | CN¥16.08 Billion | CN¥23.14 Billion | CN¥43.03 Billion | CN¥26.95 Billion | ▲ +0.8 pp |
| 2017 | 68.7% | CN¥13.24 Billion | CN¥19.26 Billion | CN¥21.50 Billion | CN¥8.27 Billion | ▲ +0.2 pp |
| 2016 | 68.5% | CN¥12.09 Billion | CN¥17.65 Billion | CN¥19.51 Billion | CN¥7.42 Billion | ▲ +34.2 pp |
| 2015 | 34.3% | CN¥2.98 Billion | CN¥8.68 Billion | CN¥9.80 Billion | CN¥6.83 Billion | ▼ -1.3 pp |
| 2014 | 35.5% | CN¥2.83 Billion | CN¥7.96 Billion | CN¥8.89 Billion | CN¥6.06 Billion | ▲ +3.5 pp |
| 2013 | 32.0% | CN¥2.25 Billion | CN¥7.02 Billion | CN¥7.30 Billion | CN¥5.05 Billion | ▼ -6.6 pp |
| 2012 | 38.6% | CN¥1.63 Billion | CN¥4.22 Billion | CN¥3.55 Billion | CN¥1.92 Billion | ▲ +1.6 pp |
| 2011 | 37.0% | CN¥1.44 Billion | CN¥3.90 Billion | CN¥2.31 Billion | CN¥871.34 Million | ▼ -3.2 pp |
| 2010 | 40.1% | CN¥1.46 Billion | CN¥3.64 Billion | CN¥2.18 Billion | CN¥714.13 Million | ▲ +4.1 pp |
| 2009 | 36.0% | CN¥1.23 Billion | CN¥3.40 Billion | CN¥1.94 Billion | CN¥712.02 Million | ▲ +0.8 pp |
| 2008 | 35.2% | CN¥1.13 Billion | CN¥3.22 Billion | CN¥1.89 Billion | CN¥751.41 Million | ▼ -19.0 pp |
| 2007 | 54.2% | CN¥1.79 Billion | CN¥3.29 Billion | CN¥4.57 Billion | CN¥2.79 Billion | ▲ +5.8 pp |
| 2006 | 48.4% | CN¥1.43 Billion | CN¥2.95 Billion | CN¥3.81 Billion | CN¥2.38 Billion | ▲ +5.0 pp |
| 2005 | 43.5% | CN¥1.22 Billion | CN¥2.81 Billion | CN¥3.46 Billion | CN¥2.24 Billion | ▲ +1.9 pp |
| 2004 | 41.6% | CN¥1.10 Billion | CN¥2.64 Billion | CN¥3.49 Billion | CN¥2.40 Billion | ▼ -7.5 pp |
| 2003 | 49.1% | CN¥1.27 Billion | CN¥2.60 Billion | CN¥3.22 Billion | CN¥1.95 Billion | ▼ -5.3 pp |
| 2002 | 54.4% | CN¥1.32 Billion | CN¥2.42 Billion | CN¥2.95 Billion | CN¥1.63 Billion | ▲ +2.5 pp |
| 2001 | 51.9% | CN¥1.19 Billion | CN¥2.28 Billion | CN¥2.58 Billion | CN¥1.39 Billion | ▲ +17.7 pp |
| 2000 | 34.2% | CN¥512.28 Million | CN¥1.50 Billion | CN¥1.99 Billion | CN¥1.48 Billion | ▼ -5.0 pp |
| 1999 | 39.2% | CN¥588.83 Million | CN¥1.50 Billion | CN¥1.95 Billion | CN¥1.36 Billion | ▼ -0.6 pp |
| 1998 | 39.8% | CN¥556.34 Million | CN¥1.40 Billion | CN¥1.98 Billion | CN¥1.43 Billion | ▼ -6.5 pp |
| 1997 | 46.3% | CN¥601.19 Million | CN¥1.30 Billion | CN¥2.06 Billion | CN¥1.46 Billion | — |